• Recherche,

Département de médecine générale : Les publications en 2016

Publié le 28 septembre 2018 Mis à jour le 14 février 2019
Le Breton J, Ferrat E, Attali C, Bercier B, Le Corvoisier P, Brixi Z, Veerabudun K, Renard V, Bastuji-Garin S. Effect of Reminders Mailed to General Practitioners on Colorectal Cancer Screening Adhesion: A Cluster-Randomised Trial. Eur J Cancer Prev. 2016 Sep;25(5):380-7.
Ferrat E, Le Breton J, Guéry E, Adeline F, Audureau E, Montagne O, Roudot-Thoraval F, Attali C, Le Corvoisier P, Renard V. Effects 4.5 Years after an Interactive General-Practitioner Educational Seminar on Antibiotic Therapy for Respiratory Tract Infections: A Randomised Controlled Trial. Fam Pract. 2016 Apr;33(2):192-9.
Ferrat E, Audureau E, Paillaud E, Liuu E, Tournigand C, Lagrange JL, Canoui-Poitrine F, Caillet P, Bastuji-Garin S; ELCAPA Study Group. Four Distinct Health Profiles in Older Patients With Cancer: Latent Class Analysis of the Prospective ELCAPA Cohort. J Gerontol A Biol Sci Med Sci. 2016 Dec;71(12):1653-1660.
• David JP, Ferrat E, Parisot J, Naga H, Lakroun S, Menasria F, Saddedine S, Natella PA, Paillaud E, Fromentin I, Bastuji-Garin S. White Matter Lesions: Prevalence and Clinical Phenotype in Asymptomatic Individuals Aged ≥ 50 Years. Dement Geriatr Cogn Disord 2016;42:159–168.
• Balkau B, Halimi S, Blicke JF, Vergès B, Avignon A, Attali C, Chartier I, Amelineau E. Reasons for non-intensification of treatment in people with type 2 diabetes receiving oral monotherapy: Outcomes from the prospective DIAttitude study. Ann Endocrinol (Paris). 2016 Sep 16. pii: S0003-4266(16)30015-4.
• Clerc P, Le Breton J. Etudier les polyprescriptions en médecine générale. Malakoff: Armand Collin; 2016, 209-224. In: Kivits J, Balard F, Fournier C, Winance M. Les recherches qualitatives en santé.
• Hanaire H, Attali C, Lecointre B, Fraysse M, Gouet D, Babel MR, Charbonnel B, Sarkozy F, Gourmelen J, Detournay B. [Determinants of the cost of initiation of insulin therapy type 2 diabetic patients in France: possible approaches to optimization]. Sante Publique. 2016 Dec 19;28(6):781-789.
• Balkau B, Halimi S, Blickle JF, Vergès B, Avignon A, Attali C, Chartier I, Amelineau E. Reasons for non-intensification of treatment in people with type 2 diabetes receiving oral monotherapy: Outcomes from the prospective DIAttitude study. Ann Endocrinol (Paris). 2016 Dec;77(6):649-657